EMA completes review on colistin

EMA recommended updating and harmonising the Summary of Product Characteristics of nationally approved colistin products throughout the EU to reflect what is currently known. The recommendations focus mainly on optimising … Continue Reading →


Reviving old antibiotics

In the face of increasing antimicrobial resistance and the lack of new agents it has become clear that we need new strategies. One of these must be to revisit old … Continue Reading →


Conference on revived antibiotics in Vienna, Austria

In the face of increasing antimicrobial resistance and the lack of new agents it has become clear that we need new strategies. One of these must be to revisit old … Continue Reading →


Bedside dosing

Lancet Infect Dis April 2014 Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions Jason A Roberts, Mohd H Abdul-Aziz, Jeff rey Lipman, Johan W Mouton, … Continue Reading →


Opportunity for Young Investigator

Department of Clinical Pharmacology at the Medical University of Vienna The Department of Clinical Pharmacology, one of the largest departments in Europe in its field and dedicated to clinical research, … Continue Reading →


Colistin based combinations

The therapy of carbapenem-resistant Gram-negative bacteria with the combination colistin+carbapenem is increasingly used in some countries. Others prefer not using an antibiotic that shows resistance in in vitro testing as … Continue Reading →